US 9102744
Conjugated anti-CD38 antibodies
granted A61KA61K2039/505A61K47/6871
Quick answer
US patent 9102744 (Conjugated anti-CD38 antibodies) held by Takeda Pharmaceutical Company Limited expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K47/6871, A61P, A61P1/00